Editorial: Racial profiling in medical research

Abstract

In a nod to the quandary faced by anyone who tries to explain the complex therapeutic effect of a drug along racial lines, the authors of the enalapril study acknowledge "the difficulty in ascertaining whether racial differences in outcomes are attributable to race or to other factors" and concede that "racial categorization [may be] only a surrogate marker for genetic or other factors."